We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund
FBT

236 hedge funds and large institutions have $860M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 79 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

1% more funds holding

Funds holding: 233 → 236 (+3)

1.02% more ownership

Funds ownership: 46.07% → 47.09% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less capital invested

Capital invested by funds: $908M → $860M (-$47.4M)

11% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 79

Holders
236
Holders Change
+3
Holders Change %
+1.29%
% of All Funds
4.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
70
Reduced
79
Closed
22
Calls
$1.81M
Puts
–
Net Calls
+$1.81M
Net Calls Change
+$999K

Top Buyers

Rank Fund Capital Flow
1
KCM
Karp Capital Management
California
+$11.1M
2
AIC
Ameritas Investment Company
Nebraska
+$6.63M
3
QAM
Q3 Asset Management
Michigan
+$5.96M
4
AA
Ancora Advisors
Ohio
+$3.61M
5
HI
Harbour Investments
Wisconsin
+$3.15M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$19.2M
2
Wells Fargo
Wells Fargo
California
-$7.19M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$5.16M
4
LPL Financial
LPL Financial
California
-$4.41M
5
RJA
Raymond James & Associates
Florida
-$3.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
IF
201
Ironwood Financial
Arizona
$32K – – –
FF
202
FourThought Financial
Florida
$32K +$33.3K +195 New
WWMSC
203
Wagner Wealth Management (South Carolina)
South Carolina
$31K – – –
BlackRock
204
BlackRock
New York
$25K – – –
S
205
SignatureFD
Georgia
$25K – – –
ASBI
206
American State Bank (Iowa)
Iowa
$24.9K – – –
FP
207
Financial Perspectives
Minnesota
$24.6K – – –
MHR
208
Matthew Hamilton Rosenberg
$24K – – –
COCM
209
Charter Oak Capital Management
New Hampshire
$23K -$3.42K -20 -13%
MA
210
MUFG Americas
New York
$22K – – –
AIP
211
Ameritas Investment Partners
Nebraska
$20K – – –
MA
212
MCF Advisors
Kentucky
$20K – – –
TC
213
Truvestments Capital
Florida
$18K – – –
TFO
214
Tarbox Family Office
California
$18K +$18.8K +110 New
TIM
215
Tortoise Investment Management
New York
$17K – – –
GWMIA
216
Global Wealth Management Investment Advisory
Florida
$17K +$17.1K +100 New
MWM
217
Mascoma Wealth Management
New Hampshire
$17K +$17.1K +100 New
APWA
218
Atlas Private Wealth Advisors
New Jersey
$14K – – –
Barclays
219
Barclays
United Kingdom
$12K – – –
NSIM
220
North Star Investment Management
Illinois
$12K – – –
PA
221
PSI Advisors
Florida
$12K +$12K +70 New
CMBA
222
C.M. Bidwell & Associates
Hawaii
$12K +$12.8K +75 New
PPWM
223
PFG Private Wealth Management
Florida
$10K +$10.2K +60 New
PCFFS
224
Pacific Center for Financial Services
California
$9K – – –
AA
225
Addison Advisors
Vermont
$7K – – –
7 8
9
10 11

FBT Hedge Fund Activity: Q3 2021 in Review

236 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2021, worth a combined $860M — down 5.2% from $908M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FBT positions and 22 closed out — a net gain of 6 holders — while 70 added to existing stakes and 79 trimmed.

The largest buyer was Karp Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Morgan Stanley, cutting an estimated $19.2M.

  • 236 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2021, up from 233 in Q2 2021.
  • Funds reported $860M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2021, down 5.2% quarter-over-quarter.
  • 28 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2021 and 22 closed out, a net change of +6 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2021 was Karp Capital Management, an estimated $11.1M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2021 was Morgan Stanley, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2021.